Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Antimicrob Agents ; 21(5): 484-7, 2003 May.
Article in English | MEDLINE | ID: mdl-12727084

ABSTRACT

A six-year retrospective study was undertaken to examine the effect of the recent penicillin G (penG) shortage on antibiotic prescribing practices at a tertiary care centre in the US. Prior to the shortage, penG was predominantly used for intrapartum prophylaxis of group B streptococcal disease. As the supply of penG ended temporarily in October 1999, penG use declined dramatically, ampicillin replaced penG in obstetrics and a shift to broad-spectrum agents was noted in non-obstetric patients potentially eligible for penG treatment. Shortage-triggered treatment changes had a negative effect on prescribing patterns, which may contribute to antibiotic resistance.


Subject(s)
Drug Prescriptions/statistics & numerical data , Drug Utilization/statistics & numerical data , Penicillin G/supply & distribution , Adult , Ampicillin/supply & distribution , Databases, Factual , Female , Hospitals , Humans , Male , Obstetrics and Gynecology Department, Hospital , Retrospective Studies , United States
2.
Int J Infect Dis ; 6(2): 108-12, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12121597

ABSTRACT

OBJECTIVE: Sexually transmitted diseases (STDs) constitute a major public health concern in developing countries. Their interest lies mainly in their diagnosis and their early treatment. Owing to lack of health education and poor living conditions inherent in underdevelopment, self-medication is common practice in these Third World countries. Therefore, the illegal sale of drugs is an important phenomenon in Africa and Asia. METHODS: An investigation, with a view to evaluating the importance of drug sales in the parallel market for the treatment of urethral discharge in Dakar, was carried out in 50 different locations in the working-class districts of the capital from 13 February to 6 March 1997. These drugs, obtained from vendors in the illegal market, were tested and analyzed using the standard physicochemical methods. RESULTS: The most frequently proposed drugs to treat male urethritis are: ampicillin 250-mg capsules (44%); oxytetracyline 250-mg capsules (24%); and cotrimoxazole 450-mg tablets (12%). In most cases (88%), these drugs were sold unpackaged; 12% were sold in blisters. Furthermore, in 90% of cases, the expiry date was not indicated. The dosage and duration of treatment were correct in only 6% of cases. The physicochemical analysis was based on the external appearance, the identification, and the dosage of the active principle. Of these drugs offered by street vendors, 53.1% had an unusual appearance; they were mainly ampicillin 250 mg (21 of 22 samples) and oxytetracycline 250 mg (6 of 12 samples). Furthermore, all active principles were identified as positive, with the exception of ampicillin 250 mg, for which only one sample of the 22 was positive; the others appeared to be flour, with no trace of the active principle. CONCLUSION: Given the extent of these illegal sales of drug and their harmful consequences for the health of the population, adequate measures should be taken to eradicate this blight. For this mission to succeed, public authorities, health professionals and populations should combine their efforts.


Subject(s)
Ampicillin/supply & distribution , Illicit Drugs/supply & distribution , Oxytetracycline/supply & distribution , Sexually Transmitted Diseases/drug therapy , Sexually Transmitted Diseases/epidemiology , Urethritis/drug therapy , Urethritis/epidemiology , Ampicillin/therapeutic use , Anti-Bacterial Agents/supply & distribution , Anti-Bacterial Agents/therapeutic use , Humans , Male , Oxytetracycline/therapeutic use , Penicillins/supply & distribution , Penicillins/therapeutic use , Public Health , Senegal
3.
Lancet ; 338(8765): 471-4, 1991 Aug 24.
Article in English | MEDLINE | ID: mdl-1678445

ABSTRACT

The recommended treatment for mild acute respiratory infections (ARI) in children is supportive care only, but many physicians, especially in developing countries, continue to prescribe antibiotic treatment because they believe it prevents progression to more severe ARI. To find out whether ampicillin treatment conferred any benefit over supportive care alone, a randomised, controlled trial was carried out among 889 children (under 5 years) with mild ARI in Indonesia. 447 were randomly allocated ampicillin (25-30 mg/kg body weight three times daily for 5 days) plus supportive care (continued breastfeeding, clearing of the nose, and paracetamol to control fever); 442 were allocated supportive care only. The treatment groups were almost identical after randomisation in terms of age, sex, level of parental education, history of measles immunisation, and fever. After 1 week the percentages cured were nearly identical (204 [46%] ampicillin; 209 [47%] control), as were the percentages of cases progressing to moderate ARI (56 [13%] vs 53 [12%]). The effect of treatment was not modified by age, sex, measles immunisation status, or the educational level of the parents. At the 2-week follow-up, the percentages cured were 62% (277) in the ampicillin group and 58% (256) in the control group; 14% of both groups had progressed to moderate ARI; and 24% (107) and 28% (123), respectively, still had mild ARI. None of the differences in outcome between the ampicillin and control groups was statistically significant. Thus, ampicillin plus supportive care offers no benefit over supportive care alone for treatment of mild ARI in young Indonesian children.


Subject(s)
Ampicillin/therapeutic use , Respiratory Tract Infections/drug therapy , Acute Disease , Ampicillin/supply & distribution , Child, Preschool , Combined Modality Therapy , Drug Evaluation , Female , Follow-Up Studies , Humans , Indonesia/epidemiology , Infant , Infant, Newborn , Male , Respiratory Tract Infections/epidemiology
4.
Afr J Med Med Sci ; 18(4): 307-10, 1989 Dec.
Article in English | MEDLINE | ID: mdl-2558563

ABSTRACT

Six brands of ampicillin and four of gentamicin were compared for their in-vitro antibacterial activity against clinical isolates of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. The minimum inhibitory concentrations obtained for each brand against each bacterial isolate compared very well with one another, and the kinetics of bactericidal activity showed that the brands of each antibiotic possessed similar activity against the clinical isolates tested.


Subject(s)
Ampicillin/pharmacology , Bacteria/drug effects , Gentamicins/pharmacology , Ampicillin/standards , Ampicillin/supply & distribution , Bacteria/isolation & purification , Gentamicins/standards , Gentamicins/supply & distribution , Humans , Microbial Sensitivity Tests , Nigeria
SELECTION OF CITATIONS
SEARCH DETAIL
...